Cannabis and psychedelics were among the few substances rated positively for relieving symptoms of eating disorders (EDs), according to a new study published in JAMA Network Open. The study, which surveyed 7,648 individuals with self-reported EDs or disordered eating, found that while prescription psychotropics were often perceived as beneficial for overall mental health, they were …
Category: Cannabis Studies
Peer-reviewed studies covering cannabis and cannabis compounds.
Study: CBD Reduces Inflammation and Redness in Rosacea, Especially When Combined With Antibiotic
A new study from researchers at The Catholic University of Korea finds that cannabidiol (CBD) may provide a promising treatment for rosacea, particularly when combined with the commonly used antibiotic metronidazole (MET). Using an animal model of rosacea, scientists found that both CBD and MET significantly reduced redness, skin thickening, and mast cell infiltration. The …
Study: Cooler Temperatures Boost Purple Pigment in Cannabis Without Reducing CBD or Flower Yield
A new study shows that exposing cannabis plants to cooler temperatures significantly increases anthocyanin production—the compound responsible for purple pigmentation—without reducing flower weight or cannabidiol (CBD) content. Published in the Journal of Cannabis Research, the study was led by researchers from the Pennsylvania Department of Agriculture and the University of Wisconsin. Using a genetically stable …
Study: Most IBD Patients Say Cannabis and CBD Relieve Symptoms; One in Three Report Reduced Opioid Use
A new study published in the journal Academia Medicine finds that a significant number of people with inflammatory bowel disease (IBD) are turning to cannabis and cannabidiol (CBD) oil to help manage symptoms that conventional medications often fail to fully address. Researchers at University Hospitals Cleveland Medical Center and Case Western Reserve University surveyed 139 …
Study: Medical Cannabis Linked to Improved Quality of Life, Reduced Opioid Use in Patients With Substance Use Disorder
According to a study published today by the journal European Addiction Research, medical cannabis can help reduce opioid use while improving sleep, anxiety, and overall quality of life in patients with substance use disorder (SUD). For the study, researchers analyzed data from 34 patients enrolled in the UK Medical Cannabis Registry, most of whom had …
Study: 90% of CBD Hemp Biomass Becomes Waste, But Anaerobic Digestion Offers a Cleaner Solution
A new study published in Resources, Conservation and Recycling evaluates the environmental impacts of various end-of-life treatments for hemp biomass generated during cannabidiol (CBD) production—and finds anaerobic digestion (AD) offers the most sustainable waste disposal option. CBD extraction leaves behind roughly 90% of the hemp plant as waste, much of which is incinerated, composted, or …
Clinical Trial: Topical CBD Gel Reduces Migraines and Improves Sleep in People With Bruxism-Related Muscle Pain
A new clinical trial conducted by researchers at the Medical University of Silesia in Katowice found that topical cannabidiol (CBD) gel significantly improved sleep quality and reduced migraine-related disability in individuals suffering from bruxism-associated muscle pain. The randomized, double-blind study involved 60 participants divided into three groups: one received a placebo, while the others received …
Study: Cannabis Use Not Linked to Kidney Function Decline or Chronic Kidney Disease
A new study conducted by researchers at Johns Hopkins University School of Medicine and the National Institutes of Health found no independent link between cannabis use and negative kidney health outcomes over time. The study, published in Cannabis and Cannabinoid Research, analyzed data from over 1,500 adults in Baltimore, Maryland. Participants were enrolled in the …
Study: Woman With Glioblastoma Enters Long-Term Remission After Using Medical Cannabis, Melatonin and Ozone Therapy
A new case study details the remarkable long-term remission of a woman diagnosed with glioblastoma multiforme (GBM), an aggressive and typically fatal brain tumor, following a treatment regimen that combined medical cannabis, high-dose melatonin and ozone therapy. The patient, a 36-year-old woman in Italy, underwent partial surgical removal of the tumor in August 2016. While …
Study: Topical Use of Cannabigerol (CBG) Shown to Reduce Rosacea Symptoms
A new study published in the International Journal of Molecular Sciences finds that topical application of cannabigerol (CBG) may effectively reduce symptoms of rosacea by targeting inflammation and vascular dysfunction. Researchers from The Catholic University of Korea used a mouse model induced with LL-37 to mimic rosacea-like skin inflammation. Mice treated with CBG showed significant …
